Clinical Trial Update: Molgramostim Nebulizer Solution Expanded Access Program Protocol

View source ↗

Summary

This document provides an updated protocol for Savara's Expanded Access Program offering molgramostim nebulizer solution to patients with Autoimmune Pulmonary A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Pulmonary Alveolar Proteinosis

Drugs mentioned

• Molgramostim (granulocyte-macrophage colony-stimulating factor (GM-CSF))

Snippet

Sponsor: Savara Inc. | Conditions: Autoimmune Pulmonary Alveolar Proteinosis | Status: AVAILABLE